Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes
Open Access
- 1 January 2021
- journal article
- research article
- Published by XMLink in Immune Network
- Vol. 21 (6) , e44
Abstract
Kim SH, et al. Immune Netw. 2021 Dec;21(6):e44. https://doi.org/10.4110/in.2021.21.e44Keywords
Funding Information
- National Research Foundation of Korea (NRF-2020R1A2C1009484, MRC-2017R1A5A2015541)
This publication has 38 references indexed in Scilit:
- Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor ImmunityFrontiers in Immunology, 2013
- The Present and Future of Peptide Vaccines for CancerThe Cancer Journal, 2011
- Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responsesExpert Review of Vaccines, 2010
- Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defectsBiomaterials, 2010
- Specificity in cancer immunotherapySeminars in Immunology, 2008
- In vitro evaluation of biodegradable microspheres with surface-bound ligandsJournal of Controlled Release, 2006
- Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro modelInternational Journal of Pharmaceutics, 2005
- Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFNJournal of Experimental Medicine, 2004
- Clinical implications of antigen transfer mechanisms from malignant to dendritic cellsExperimental Hematology, 2002
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994